Working... Menu

High Dose Intensity Modulated Radiation Therapy in the Cervical Cancer With Metastatic Lymphadenopathies.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT01730651
Recruitment Status : Recruiting
First Posted : November 21, 2012
Last Update Posted : September 19, 2017
Keimyung University Dongsan Medical Center
Information provided by (Responsible Party):
Joo-Young Kim, National Cancer Center, Korea

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2022
  Estimated Study Completion Date : July 2022